Sun Pharmaceutical
- All
- News
- Videos
-
Sun Pharma Flags Revenue Drop Following 'IT Security Incident' in March: Details
Sun Pharmaceutical Industries on Sunday revealed in a filing that the firm would see a revenue drop in a few of its businesses and incur some expenses due to an "IT security incident" in March. The drugmaker's IT systems were affected by a breach of certain file systems and theft of some company and personal data, while a ransomware group has claim...
-
Ransomware Attack To Hurt Revenue At Sun Pharmaceutical
Sun Pharmaceutical Industries Ltd. expects revenue to fall as measures taken by India's top drugmaker to contain an information technology security breach in early March impacted operations.
-
Sun Pharma Says Gujarat Facility Listed Under US Regulator's Import Alert
The import alert means all future shipments of products made at Halol can be refused admission to the US market until the facility becomes compliant with the FDA's Current Good Manufacturing Practice standards,
-
Sun Pharmaceutical Industries Chairman Israel Makov To Retire On Aug 29
Drug major Sun Pharmaceutical Industries on Wednesday said its Chairman Israel Makov will retire from the company on August 29, 2022.
-
Sun Pharma Shares Tank Over 4% After Q4 Earnings
Shares of Sun Pharmaceutical Industries fell by over 4 per cent in morning trade on Tuesday a day after the company said its consolidated net loss stood at Rs 2,277 crore for the fourth quarter ended March 2022, mainly on account of a one-time exceptional loss.
-
Sun Pharma Records Rs 2,277 Crore March Quarter Net Loss
Sun Pharmaceutical Industries on Monday said its consolidated net loss stood at Rs 2,277 crore for the fourth quarter ended March 2022
-
Pharma Stocks Gain After Centre Approves Use Of COVID Pill Molnupiravir
Pharma Stocks Today: Pharmaceutical shares such as Cipla, Dr Reddy's Laboratories, Torrent Pharma, Sun Pharma Industries gained around two per cent each on Wednesday
-
Sun Pharma To Make Eli Lilly's Covid Medicine In India; Shares Gain
Sun Pharmaceutical shares rose as much as 3.51% to hit an intraday high of Rs 703.40 after it signed an agreement with Eli Lilly to make baricitinib.
-
Merck Taps 5 Indian Drugmakers To Expand Covid Drug Production
Merck & Co Inc said on Tuesday it had partnered with five Indian generic drugmakers, including Cipla Ltd and Sun Pharmaceutical Industries Ltd, to expand production and access to its experimental COVID-19 drug.
-
Pharma Stocks Rally On High Demand For Medicines Amid Rising COVID Cases
Pharmaceutical stocks today: On Friday, Cipla opened on the NSE at Rs 840.90, touching an intra day high of Rs 892.30 and an intra day low of Rs 836.65, in the session so far
-
Volume Decline Muted Pharmaceutical Market Growth In November
The pharmaceutical market reported 128.3 billion total sales in November 2020 and decline in volume can be attributed to the lower sales of the acute therapy products
-
Sun Pharma Company Launches COVID-19 Drug Favipiravir In India
Sun Pharmaceutical Industries has said it has launched Favipiravir (200 mg) in India under the brand FluGuard at an economical price of Rs 35 per tablet for the treatment of mild to moderate cases of COVID-19.
-
Sun Pharma Acquires Canada's Aquinox Pharma For $8.2 Million, Shares Gain
Aquinox Pharmaceuticals is a research and development company focused on pharmaceutical products for the purpose of their commercialisation, Sun Pharma said.
-
COVID-19 Crisis: Sun Pharma Testing Plant-Based Drug As Potential Treatment
Drug makers around the world are rushing to develop a treatment or vaccine for the fast-spreading novel coronavirus that has killed over 3,90,000 people and ravaged financial markets.
-
Sun Pharma Flags Hypertension Drug Shortage Due To Supply Constraint
Indian companies are the main supplier of generic drugs to the world and procure almost 70 per centof the active pharmaceutical ingredients (APIs) for their medicines from China. The coronavirus outbreak has disrupted international businesses dependent on Chinese supplies.
-
Sun Pharma Flags Revenue Drop Following 'IT Security Incident' in March: Details
Sun Pharmaceutical Industries on Sunday revealed in a filing that the firm would see a revenue drop in a few of its businesses and incur some expenses due to an "IT security incident" in March. The drugmaker's IT systems were affected by a breach of certain file systems and theft of some company and personal data, while a ransomware group has claim...
-
Ransomware Attack To Hurt Revenue At Sun Pharmaceutical
Sun Pharmaceutical Industries Ltd. expects revenue to fall as measures taken by India's top drugmaker to contain an information technology security breach in early March impacted operations.
-
Sun Pharma Says Gujarat Facility Listed Under US Regulator's Import Alert
The import alert means all future shipments of products made at Halol can be refused admission to the US market until the facility becomes compliant with the FDA's Current Good Manufacturing Practice standards,
-
Sun Pharmaceutical Industries Chairman Israel Makov To Retire On Aug 29
Drug major Sun Pharmaceutical Industries on Wednesday said its Chairman Israel Makov will retire from the company on August 29, 2022.
-
Sun Pharma Shares Tank Over 4% After Q4 Earnings
Shares of Sun Pharmaceutical Industries fell by over 4 per cent in morning trade on Tuesday a day after the company said its consolidated net loss stood at Rs 2,277 crore for the fourth quarter ended March 2022, mainly on account of a one-time exceptional loss.
-
Sun Pharma Records Rs 2,277 Crore March Quarter Net Loss
Sun Pharmaceutical Industries on Monday said its consolidated net loss stood at Rs 2,277 crore for the fourth quarter ended March 2022
-
Pharma Stocks Gain After Centre Approves Use Of COVID Pill Molnupiravir
Pharma Stocks Today: Pharmaceutical shares such as Cipla, Dr Reddy's Laboratories, Torrent Pharma, Sun Pharma Industries gained around two per cent each on Wednesday
-
Sun Pharma To Make Eli Lilly's Covid Medicine In India; Shares Gain
Sun Pharmaceutical shares rose as much as 3.51% to hit an intraday high of Rs 703.40 after it signed an agreement with Eli Lilly to make baricitinib.
-
Merck Taps 5 Indian Drugmakers To Expand Covid Drug Production
Merck & Co Inc said on Tuesday it had partnered with five Indian generic drugmakers, including Cipla Ltd and Sun Pharmaceutical Industries Ltd, to expand production and access to its experimental COVID-19 drug.
-
Pharma Stocks Rally On High Demand For Medicines Amid Rising COVID Cases
Pharmaceutical stocks today: On Friday, Cipla opened on the NSE at Rs 840.90, touching an intra day high of Rs 892.30 and an intra day low of Rs 836.65, in the session so far
-
Volume Decline Muted Pharmaceutical Market Growth In November
The pharmaceutical market reported 128.3 billion total sales in November 2020 and decline in volume can be attributed to the lower sales of the acute therapy products
-
Sun Pharma Company Launches COVID-19 Drug Favipiravir In India
Sun Pharmaceutical Industries has said it has launched Favipiravir (200 mg) in India under the brand FluGuard at an economical price of Rs 35 per tablet for the treatment of mild to moderate cases of COVID-19.
-
Sun Pharma Acquires Canada's Aquinox Pharma For $8.2 Million, Shares Gain
Aquinox Pharmaceuticals is a research and development company focused on pharmaceutical products for the purpose of their commercialisation, Sun Pharma said.
-
COVID-19 Crisis: Sun Pharma Testing Plant-Based Drug As Potential Treatment
Drug makers around the world are rushing to develop a treatment or vaccine for the fast-spreading novel coronavirus that has killed over 3,90,000 people and ravaged financial markets.
-
Sun Pharma Flags Hypertension Drug Shortage Due To Supply Constraint
Indian companies are the main supplier of generic drugs to the world and procure almost 70 per centof the active pharmaceutical ingredients (APIs) for their medicines from China. The coronavirus outbreak has disrupted international businesses dependent on Chinese supplies.
